ArticlebioRxiv : the preprint server for biology2025
Leveraging learned representations and multitask learning for lysine methylation site discovery.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lysine methylation is a dynamic and reversible post-translational modification of proteins carried out by lysine methyltransferase enzymes. The role of this modification in epigenetics and gene regulation is relatively well understood, but our understanding of the extent and the role of lysine methylation of non-histone substrates remains fairly limited. Several lysine methyltransferases which methylate non-histone substrates are overexpressed in a number of cancers and are believed to be key drivers of cancer progression. There is great incentive to identify the lysine methylome, as this is a key step in identifying drug targets. While numerous computational models have been developed in the last decade to identify novel lysine methylation sites, the accuracy of these model has been modest, leaving much room for improvement. In this work, we leverage the most recent advancements in deep learning and present a transformer-based model for lysine methylation site prediction which achieves state-of-the-art accuracy. In addition, we show that other post-translational modifications of lysine are informative and that multitask learning is an effective way to integrate this prior knowledge into our lysine methylation site predictor, MethylSight 2.0. Finally, we validate our model by means of mass spectrometry experiments and identify 68 novel lysine methylation sites. This work constitutes another contribution towards the completion of a comprehensive map of the lysine methylome.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.